Alvotech
Price & Volume
Stats
See more52W Range | $4.70-$13.70 |
Market Cap | $1.7B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $562.4M |
Revenue Growth (YoY) | -12.8% |
Gross Profit (12 Mos) | $303M |
Diluted EPS | $0.23 |
News
See moreYahoo Finance • 5 days ago
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Yahoo Finance • 5 days ago
European Commission Approves Alvotech's AVT03 As A Biosimilar To Prolia And Xgeva
About
CEO | Mr. Vilhelm Robert Wessman |
Address | 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,012 |
